Retrospective evaluation of patients with chronic spontaneous urticaria using omalizumab during the COVID‐19 pandemic-Reference-Cited by-同舟云学术

Retrospective evaluation of patients with chronic spontaneous urticaria using omalizumab during the COVID‐19 pandemic

Published:2022-01-04 Issue:2 Volume:21 Page:431-434
ISSN:1473-2130
Container-title:Journal of Cosmetic Dermatology
language:en
Short-container-title:J of Cosmetic Dermatology

Author:

Koç Yıldırım Sema¹^ORCID,Demirel Öğüt Neslihan¹^ORCID,Erbağcı Ece¹^ORCID

Affiliation:

1. Department of Dermatology and Venereology Uşak University Training and Research Hospital Uşak Turkey

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jocd.14725

Reference18 articles.

1. Omalizumab and COVID‐19 treatment: Could it help?

2. Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID‐19 pandemic: statement of dermatoallergy working group of the Turkish society of dermatology/COVID‐19 pandemisi suresince urtiker ve atopik dermatitte sistemik tedavilerin kullanimina iliskin oneriler: Turk Dermatoloji Dernegi Dermatoallerji Calisma Grubu Bildirisi;Salman A;Turk Arch Dermatol Venereol,2020

3. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic

4. The Turkish Guideline for the Diagnosis and Management of Urticaria-2016

5. Association between urticaria and virus infections: A systematic review

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines among Patients with Immune-Mediated Dermatological Diseases: A Systematic Review and Meta-analysis;Acta Dermato-Venereologica;2024-05-02

2. The effect of COVID-19 and COVID-19 vaccines on chronic spontaneous urticaria: single center experience;Alergologia Polska - Polish Journal of Allergology;2024

3. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study;Journal of Allergy and Clinical Immunology;2023-11

4. The effect of COVID-19 on patients recieving omalizumab treatment;Revue Française d'Allergologie;2023-03

5. Safely use of omalizumab during SARS‐CoV ‐2 infection in patients with chronic spontaneous urticaria;Journal of Cosmetic Dermatology;2022-11-30